MME and mantle cell lymphoma: In comparison to a control group of patients with CD10-negative MCL, the clinical features of the patients with CD10+ MCL were very similar; the only exception was that patients with CD10+ MCL showed a lower male predominance (male:female ratio of 1.3:1 vs 5.1:1 in typical CD10-negative MCL patients, p = 0.002).